2026 Autoimmune Neurology Conference | C8 - Case Studies

Date Friday 08/07/26

Time 05:30 PM - 07:00 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Case Studies Program

Director(s) Anastasia Zekeridou, MD, PhD, FAAN, Eoin P. Flanagan, MBBCh, FAAN, Stacey Clardy, MD, PhD, FAAN

Topic(s) Autoimmune Neurology

CME Available 1.50 CME credits

Event Timeline
05:30 PM - 05:45 PM CDT	Speaker	Case #1 Denis T. Balaban, MD
05:45 PM - 06:00 PM CDT	Speaker	Case #2 Max Herman, MD
06:00 PM - 06:15 PM CDT	Speaker	Case #3 Sydney Lee, MD
06:15 PM - 06:30 PM CDT	Speaker	Case #4 Kristin M. Galetta, MD
06:30 PM - 06:45 PM CDT	Speaker	Case #5 Nisa Vorasoot, MD
06:45 PM - 07:00 PM CDT	Speaker	Case #6 Naveen K. Paramasivan, MD

Faculty Disclosures
Sydney Lee, MD	Dr. Lee has nothing to disclose.
Denis T. Balaban, MD	Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infucare. Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedLive. The institution of Dr. Balaban has received research support from ArgenX.
Kristin M. Galetta, MD	Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Max Herman, MD	Dr. Herman has nothing to disclose.
Nisa Vorasoot, MD	Dr. Vorasoot has nothing to disclose.
Anastasia Zekeridou, MD, PhD, FAAN	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Naveen K. Paramasivan, MD	Dr. Paramasivan has nothing to disclose.